MELVILLE, N.Y.--(BUSINESS WIRE)--OSI Pharmaceuticals, Inc. (Nasdaq: OSIP) today provided an informational update summarizing highlights from nearly 70 presentations related to the company’s oncology portfolio featured at this year’s Annual Meeting of the American Association of Cancer Research (AACR) held from April 12th-16th in San Diego, California.
